Cargando…
A spike-targeting bispecific T cell engager strategy provides dual layer protection against SARS-CoV-2 infection in vivo
Neutralizing antibodies exert a potent inhibitory effect on viral entry; however, they are less effective in therapeutic models than in prophylactic models, presumably because of their limited efficacy in eliminating virus-producing cells via Fc-mediated cytotoxicity. Herein, we present a SARS-CoV-2...
Autores principales: | Li, Fanlin, Xu, Wei, Zhang, Xiaoqing, Wang, Wanting, Su, Shan, Han, Ping, Wang, Haiyong, Xu, Yanqin, Li, Min, Fan, Lilv, Zhang, Huihui, Dai, Qiang, Lin, Hao, Qi, Xinyue, Liang, Jie, Wang, Xin, Jiang, Shibo, Xie, Youhua, Lu, Lu, Yang, Xuanming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234585/ https://www.ncbi.nlm.nih.gov/pubmed/37264086 http://dx.doi.org/10.1038/s42003-023-04955-3 |
Ejemplares similares
-
Bcl-2 Enhances Chimeric Antigen Receptor T Cell Persistence by Reducing Activation-Induced Apoptosis
por: Wang, Haiyong, et al.
Publicado: (2021) -
Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection
por: Zhang, Xiaoqing, et al.
Publicado: (2021) -
A CLDN18.2-Targeting Bispecific T Cell Co-Stimulatory Activator for Cancer Immunotherapy
por: Liang, Jie, et al.
Publicado: (2021) -
4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2(nd) Generation Chimeric Antigen Receptor-Modified T Cells
por: Dai, Qiang, et al.
Publicado: (2020) -
Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC
por: Fan, Lilv, et al.
Publicado: (2021)